Effective or predatory funding? Evaluating the hidden costs of grant applications

Standard

Effective or predatory funding? Evaluating the hidden costs of grant applications. / Dresler, Martin; Buddeberg, Eva; Endesfelder, Ulrike; Haaker, Jan; Hof, Christian; Kretschmer, Robert; Pflüger, Dirk; Schmidt, Fabian.

In: IMMUNOL CELL BIOL, Vol. 101, No. 2, 02.2023, p. 104-111.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Dresler, M, Buddeberg, E, Endesfelder, U, Haaker, J, Hof, C, Kretschmer, R, Pflüger, D & Schmidt, F 2023, 'Effective or predatory funding? Evaluating the hidden costs of grant applications', IMMUNOL CELL BIOL, vol. 101, no. 2, pp. 104-111. https://doi.org/10.1111/imcb.12592

APA

Dresler, M., Buddeberg, E., Endesfelder, U., Haaker, J., Hof, C., Kretschmer, R., Pflüger, D., & Schmidt, F. (2023). Effective or predatory funding? Evaluating the hidden costs of grant applications. IMMUNOL CELL BIOL, 101(2), 104-111. https://doi.org/10.1111/imcb.12592

Vancouver

Dresler M, Buddeberg E, Endesfelder U, Haaker J, Hof C, Kretschmer R et al. Effective or predatory funding? Evaluating the hidden costs of grant applications. IMMUNOL CELL BIOL. 2023 Feb;101(2):104-111. https://doi.org/10.1111/imcb.12592

Bibtex

@article{82748bdef8b94ba5bd3f5d71d29fbbdf,
title = "Effective or predatory funding? Evaluating the hidden costs of grant applications",
abstract = "Researchers are spending an increasing fraction of their time on applying for funding; however, the current funding system has considerable deficiencies in reliably evaluating the merit of research proposals, despite extensive efforts on the sides of applicants, grant reviewers and decision committees. For some funding schemes, the systemic costs of the application process as a whole can even outweigh the granted resources-a phenomenon that could be considered as predatory funding. We present five recommendations to remedy this unsatisfactory situation.",
author = "Martin Dresler and Eva Buddeberg and Ulrike Endesfelder and Jan Haaker and Christian Hof and Robert Kretschmer and Dirk Pfl{\"u}ger and Fabian Schmidt",
note = "{\textcopyright} 2022 The Authors. Immunology & Cell Biology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.",
year = "2023",
month = feb,
doi = "10.1111/imcb.12592",
language = "English",
volume = "101",
pages = "104--111",
journal = "IMMUNOL CELL BIOL",
issn = "0818-9641",
publisher = "John Wiley & Sons",
number = "2",

}

RIS

TY - JOUR

T1 - Effective or predatory funding? Evaluating the hidden costs of grant applications

AU - Dresler, Martin

AU - Buddeberg, Eva

AU - Endesfelder, Ulrike

AU - Haaker, Jan

AU - Hof, Christian

AU - Kretschmer, Robert

AU - Pflüger, Dirk

AU - Schmidt, Fabian

N1 - © 2022 The Authors. Immunology & Cell Biology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.

PY - 2023/2

Y1 - 2023/2

N2 - Researchers are spending an increasing fraction of their time on applying for funding; however, the current funding system has considerable deficiencies in reliably evaluating the merit of research proposals, despite extensive efforts on the sides of applicants, grant reviewers and decision committees. For some funding schemes, the systemic costs of the application process as a whole can even outweigh the granted resources-a phenomenon that could be considered as predatory funding. We present five recommendations to remedy this unsatisfactory situation.

AB - Researchers are spending an increasing fraction of their time on applying for funding; however, the current funding system has considerable deficiencies in reliably evaluating the merit of research proposals, despite extensive efforts on the sides of applicants, grant reviewers and decision committees. For some funding schemes, the systemic costs of the application process as a whole can even outweigh the granted resources-a phenomenon that could be considered as predatory funding. We present five recommendations to remedy this unsatisfactory situation.

U2 - 10.1111/imcb.12592

DO - 10.1111/imcb.12592

M3 - SCORING: Journal article

C2 - 36214095

VL - 101

SP - 104

EP - 111

JO - IMMUNOL CELL BIOL

JF - IMMUNOL CELL BIOL

SN - 0818-9641

IS - 2

ER -